FDA puts Ver­tex’s new Type 1 di­a­betes cell ther­a­py IND on hold; In­sil­i­co sets up for PhII of AI drug

3 years ago
R&D
News Briefing

Ab­b­Vie signs mR­NA pact with An­i­ma Biotech for $42M up­front

3 years ago
Deals
AI

Ei­sai fol­lows fam­i­ly ties with name for new­ly ap­proved Alzheimer's drug Leqem­bi

3 years ago
Pharma
Marketing

4D Mol­e­c­u­lar paus­es en­roll­ment in Fab­ry tri­als af­ter kid­ney prob­lems in three pa­tients

3 years ago
R&D
Cell/Gene Tx

ICY­MI: FDA com­mis­sion­er calls for more on­shoring of clin­i­cal tri­als

3 years ago
FDA+

Mar­ket­ingRx roundup: Blue­bird bio pro­motes sick­le cell aware­ness; Pfiz­er, BioN­Tech en­cour­age boost­ers in South

3 years ago
R&D

Q&A: Genen­tech's first mar­ket­ing chief Er­i­ca Tay­lor on lessons from the pan­dem­ic, and what's next for the Roche group

3 years ago
Pharma
Marketing

Jasper scraps piv­otal plans but adds a new in­di­ca­tion as more biotechs re­vise pipelines

3 years ago
Startups
R&D

Sutro shells out lat­est up­date on ovar­i­an can­cer treat­ment, plans for piv­otal tri­al

3 years ago
R&D

BioN­Tech buys out AI part­ner In­staDeep for $440M in bid to be­come ‘tech­nol­o­gy com­pa­ny’

3 years ago
Startups
Deals

Al­to touts new PhI­Ia de­pres­sion da­ta with plans to keep charg­ing for­ward

3 years ago
R&D

What we're see­ing at JPM so far: Up­com­ing BD moves, pipeline up­dates and more

3 years ago
Pharma

Big Phar­mas main­tain pause of Twit­ter ads, spend­ing drops to ze­ro for first week of 2023

3 years ago
Pharma
Marketing

Calithera to shut down af­ter fail­ing to re­vive Take­da as­sets

3 years ago
People

Up­dat­ed: Mod­er­na rounds out 2022 with $18.4B in vac­cine sales, boosts R&D bud­get for 2023

3 years ago
Pharma
Coronavirus

Up­dat­ed: Ag­i­lent throws down $725M to dou­ble man­u­fac­tur­ing ca­pac­i­ty for nu­cle­ic acids to meet API de­mand

3 years ago
Financing
Manufacturing

Novotech's lat­est ac­qui­si­tions grow its US pres­ence and plant a Eu­ro­pean foothold

3 years ago
Deals
Outsourcing

Teva's opi­oid set­tle­ment moves for­ward with par­tic­i­pa­tion from 48 states

3 years ago
Pharma
Law

FDA ac­cepts one, de­lays an­oth­er; Da­ta, deals and dol­lars for slate of biotechs

3 years ago
News Briefing

Io­n­is sells par­tial stake in roy­al­ties from Spin­raza and No­var­tis car­dio drug to Roy­al­ty Phar­ma for $500M up­front

3 years ago
Deals

Voy­ager goes big, se­cur­ing mul­ti-bil­lion dol­lar gene ther­a­py de­vel­op­ment deal with Neu­ro­crine

3 years ago
Deals
Cell/Gene Tx

Emer­gent to cut over 130 po­si­tions to kick off new year

3 years ago
People
Manufacturing

Day One to file NDA for pe­di­atric brain can­cer drug by sum­mer

3 years ago
R&D

New year, new CEOs for Covid vac­cine mak­ers Cure­Vac and No­vavax

3 years ago
Coronavirus
First page Previous page 404405406407408409410 Next page Last page
A service from the Financial Times